Skip to main navigation
Back
revance revance
  • Contact Revance
  • Login
Menu
  • Aesthetics
    Back Aesthetics
    • Overview
    • RHA®
    • HintMD
    • Neuromodulator
    • Neuromodulator Uses
    • Clinical Highlights
  • Therapeutics
    Back Therapeutics
    • Overview
    • Cervical Dystonia
    • Upper Limb Spasticity
    • Plantar Fasciitis
    • Clinical Highlights
  • Investors
    Back Investors
    LATEST NEWS
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection All News
    • Investor Relations
    • Press Releases
    • Events & Webcasts
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Investor FAQ
  • Company
    Back Company
    OUR LATEST
    • Our Latest
    • December 22, 2020
    Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Our Latest
    • Overview
    • About Revance
    • Leadership Team
    • Board of Directors
    • Partnerships
    • Investigator Sponsored Trials
    • Corporate Social Responsibility
    • Contact Revance
  • News
  • Careers
    Back Careers
    • Overview
    • Career Opportunities
    • Culture
    • Benefits & Perks
  • facebook
  • instagram
  • twitter
  • linkedin
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • Contact Revance
  • Login

© Copyright 2021

All Rights Reserved

Terms of Use

Privacy Policy

Breadcrumb

  • Home
  • Investors
  • Events webcasts

Events & Webcasts

Events & Webcasts

Featured Materials

Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020
Video Link - Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020
Infographic 2 - Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020
Infographic 1 - Phase 3 Cervical Dystonia Presentation October 2020
October 14, 2020

Upcoming Events

More events are coming soon.

Archived Events

39th Annual J.P. Morgan Healthcare Conference
January 14, 2021 3:40 PM EST
Listen to Webcast
Piper Sandler 32nd Annual Virtual Healthcare Conference
December 01, 2020
Listen to Webcast
Stifel Healthcare Conference
November 17, 2020 2:00 PM EST
Listen to Webcast
Credit Suisse 29th Annual Healthcare Conference
November 10, 2020 10:15 AM EST
Listen to Webcast
Revance Therapeutics 2020 Third Quarter Financial Results
November 09, 2020 4:30 PM EST
Listen to Webcast
ASPEN-1 Phase 3 Results Conference Call
October 14, 2020 5:30 AM PDT
Listen to Webcast

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Webcasts
    • Presentations and Corporate Materials
    • Video Library
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
image description

Revance - Shareholder Tools

  • Print Page
  • Printed Materials
  • Email Alerts
  • Download Library
  • RSS News Feeds
  • Share
  • Search

Keep up with Revance

revance
1222 Demonbreun St
Suite 2000
Nashville, TN 37203
+1 (510) 742-3400
  • facebook
  • instagram
  • twitter
  • linkedin

Aesthetics

  • Overview
  • RHA®
  • HintMD
  • Neuromodulator
  • Neuromodulator Uses
  • Clinical Highlights

Therapeutics

  • Overview
  • Cervical Dystonia
  • Upper Limb Spasticity
  • Plantar Fasciitis
  • Clinical Highlights

Investors

  • Investor Relations
  • Press Releases
  • Events & Webcasts
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQ

Company

  • Overview
  • About Revance
  • Leadership Team
  • Board of Directors
  • Partnerships
  • Investigator Sponsored Trials
  • Corporate Social Responsibility
  • Contact Revance

News

  • All News
  • In the News
  • Our Latest

Careers

  • Overview
  • Career Opportunities
  • Culture
  • Benefits & Perks
  • © Copyright 2021
  • All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • Corporate Social Media Community Guidelines
Back to top
  • Facebook
  • LinkedIn